Dose Ranging Study of SAR443765 Compared With Placebo-control in Adult Participants With Moderate to Severe Asthma
18-80 years
All genders
Phase 2
Interventional
This is a Phase 2b, global, multicenter, randomized, double-blind, placebo-controlled, parallel group, dose ranging study to assess the efficacy, safety, and tolerability of add-on therapy with SC SAR443765 in adult participants aged 18 to 80 years, (inclusive) with moderate to severe asthma.